(Q44256906)

English

Plasma pharmacokinetics of Idarubicin and its 13-hydroxymetabolite after intravenous and oral administration under fasting and non-fasting conditions

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Plasma pharmacokinetics of Idarubicin and its 13-hydroxymetabolite after intravenous and oral administration under fasting and non-fasting conditions (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Eksborg S

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Söderberg M

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Nilsson B

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Antila K

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 January 1990

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Acta Oncologica

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

921-925

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study.

1 reference

https://api.crossref.org/works/10.3109%2F02841869009096390

21 January 2018

Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies

1 reference

https://api.crossref.org/works/10.3109%2F02841869009096390

21 January 2018

Pharmacokinetics of idarubicin (4-demethoxydaunorubicin; IMI-30; NSC 256439) following intravenous and oral administration in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.3109%2F02841869009096390

21 January 2018

Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administration.

1 reference

https://api.crossref.org/works/10.3109%2F02841869009096390

21 January 2018

Interactions affecting drug absorption

1 reference

https://api.crossref.org/works/10.3109%2F02841869009096390

21 January 2018

High-dose daunorubicin therapy for acute nonlymphocytic leukemia: correlation of response and toxicity with pharmacokinetics and intracellular daunorubicin reductase activity.

1 reference

https://api.crossref.org/works/10.3109%2F02841869009096390

21 January 2018

Plasma concentration-response relationships for some cardiovascular effects of dihydropyridines in healthy subjects.

1 reference

https://api.crossref.org/works/10.3109%2F02841869009096390

21 January 2018

Pharmacokinetics of oral idarubicin in breast cancer patients with reference to antitumor activity and side effects

1 reference

https://api.crossref.org/works/10.3109%2F02841869009096390

21 January 2018

Identifiers

10.3109/02841869009096390

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44256906&oldid=2143787290"